Pfizer Investigational Site
London, England, SW3 6HP, United Kingdom
NCT Number: NCT00483353
The current study will investigate nasal inflammatory markers obtained by filter paper collection techniques, in subjects with allergic rhinitis, determining the most appropriate time points and handling conditions, prior to running a larger study with subjects with allergic rhinitis.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1
London, England, SW3 6HP, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pfizer
Industry
A Pilot Study to Explore the Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers in Subjects With Seasonal Allergic Rhinitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05346718
Allergic Rhinitis, Birch Pollen Allergy
Hanover, Lower Saxony, Germany
View Trial DetailsNCT07052097
Hypersensitivity, Hypersensitivity, Immediate
Beijing, Beijing Municipality, China
View Trial DetailsNCT03369704
Hypersensitivity, Hypersensitivity, Immediate
Chiba, Japan
View Trial DetailsNCT06046391
Hypersensitivity, Hypersensitivity, Immediate
Beijing, Beijing Municipality, China
View Trial Details